Withdrawal of oxyphenisatin acetate, diacetoxydiphenolisatin and triacetyldiphenolisatin from the Australian market.
D000328:Adult; D000368:Aged; D001315:Australia; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002779:Cholestasis / Q000139:chemically induced; D004335:Drug and Narcotic Control; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged
D007211:Indoles